MAFODOTIN,
McMMAF,
UNII-O19V2N6W9T,
Mafodotin [USAN],
863971-19-1,
O19V2N6W9T,
Mafodotin (USAN),
MC-MMAF,
Maleimidocaproyl monomethylauristatin F,
CHEMBL2107813,
SCHEMBL10220875,
mc-MMAF, mcMMAF, SGD-1269,
AKOS030526943,
ZINC150341961,
CS-5344,
HY-15578,
D10339,
L-Phenylalanine, N-(6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl)-N-methyl-L- valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(alphaR,betaR,2S)-beta- methoxy-alpha-methyl-2-pyrrolidinepropanoyl-,
N-((2R,3R)-3-((2S)-1-((3R,4S,5S)-4-((N-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1- yl)hexanoyl)-N-methyl-L-valyl-L-valyl)methylamino)-3-methoxy-5- methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine,
N-[(2R,3R)-2-Methyl-3-methoxy-3-[1-[(3R,4S,5S)-3-methoxy-4-[[N-[6-(2,5-dioxo-3-pyrroline-1-yl)hexanoyl]-N-methyl-L-Val-L-Val-](methyl)amino]-5-methylheptanoyl]pyrrolidine-2alpha-yl]propanoyl]-L-phenylalanine,